Blood Glucose Monitor Market

The global blood glucose monitor market is projected to reach 25.4 billion in 2030 from USD 16.5 billion in 2025, at a CAGR of 9.1% during the forecast period.

There are several key drivers for the blood glucose monitor market. One of these is the rising prevalence of diabetes and prediabetes, sedentary lifestyles, unhealthy dietary habits, and aging populations. The demand is also being fueled by growing awareness of diabetes management and improving access to diagnostic and monitoring devices, especially in developing and low-income countries. However, factors such as the high cost of advanced glucose monitoring systems, limited affordability among lower-income patients, and insufficient reimbursement coverage are expected to restrain market growth to some extent.

Prominent players in the global blood glucose monitor market include Abbott Laboratories (US), DexCom, Inc. (US), Medtronic (Ireland), F. Hoffmann-La Roche Ltd. (Switzerland), Sinocare (China), B. Braun SE (Germany), and Ascensia Diabetes Care Holdings AG (Switzerland).

To know about the assumptions considered for the study download the pdf brochure

In April 2025, DexCom, Inc. (US) announced that the DexCom G7 15 Day Continuous Glucose Monitoring System had been approved by the US FDA for use by people over the age of 18 with diabetes.

In June 2024, Abbott Laboratories (US) announced the US FDA clearance for two new over-the-counter continuous glucose monitoring (CGM) systems: Lingo and Libre Rio, which are based on Abbott's world-leading FreeStyle Libre continuous glucose monitoring technology.

Abbott Laboratories (US) is a global healthcare leader operating in over 160 countries. Through its Medical Devices division, the company has built a strong presence in diabetes care, offering both continuous and traditional blood glucose monitoring solutions under the FreeStyle brand. Its flagship FreeStyle Libre system, comprising sensors, test strips, data management software, and related accessories, has revolutionized glucose tracking by providing real-time insights for better diabetes management. Additionally, the launch of the Lingo continuous glucose monitoring system for broader health and wellness applications has further strengthened Abbott’s position as an innovation leader in the global blood glucose monitor market.

DexCom, Inc. (US) develops, manufactures, and commercializes real-time CGM systems that provide continuous, actionable insights into glucose levels without the need for routine fingersticks. Its flagship DexCom G6 and next-generation G7 systems, supported by integrated mobile applications and data platforms, enable improved glycemic control and patient engagement. With a strong global presence across North America, Europe, and expanding markets in the Asia Pacific, DexCom has established itself as a key innovator and market leader in CGM solutions, driving advancements in digital health and diabetes care.

Medtronic (Ireland) has a diversified portfolio encompassing cardiovascular, neuroscience, surgical, and diabetes care solutions. In the field of diabetes management, the company develops and markets advanced insulin delivery systems integrated with continuous glucose monitoring (CGM) technologies. Its flagship MiniMed insulin pump series, paired with Guardian CGM sensors and intelligent insulin management software, enables real-time glucose tracking and automated insulin delivery to help patients achieve better glycemic control. With a strong footprint across North America, Europe, and emerging markets, Medtronic continues to drive innovation in diabetes care, advancing toward fully closed-loop systems and strengthening its position as a global leader in the blood glucose monitor market.

MARKET RANKING

In the global blood glucose monitor market, competition is moderately consolidated, with the top five players accounting for over 55% of the total market share. Abbott Laboratories (US) holds a leading position driven by its strong FreeStyle portfolio, extensive global reach, and continuous innovation in continuous glucose monitoring (CGM) technologies. Dexcom, Inc. (US), is another major player, leveraging its advanced G6 and G7 CGM systems, user-centric design, and robust digital health integration. Medtronic (Ireland) maintains a significant presence with its MiniMed insulin pump series and Guardian CGM sensors, advancing toward fully closed-loop systems for enhanced diabetes management. F. Hoffmann-La Roche Ltd (Switzerland) continues to strengthen its market position through its Accu-Chek line of glucose monitoring systems, supported by broad distribution and patient support programs. Sinocare (China), one of the leading players in Asia, is rapidly expanding its footprint globally with affordable and reliable glucose monitoring devices tailored for emerging markets. Collectively, these companies set industry benchmarks in accuracy, accessibility, and technological advancement, shaping the direction of the global blood glucose monitor market.

Related Reports:

Blood Glucose Monitor Market by Product Type (Self blood glucose monitoring, Professional point of care), Application (Diabetes management, Health & Wellness Monitoring), Test site (Fingertip, Upper arm), End User (Self/Homecare) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com